Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss‐of‐function variant

Vinpocetine is a synthetic derivative of the alkaloid vincamine and has been used as a dietary supplement for decades. Following a positive report of the use of vinpocetine in a patient with a loss‐of‐function GABRB3 variant, we here describe another patient with a loss‐of‐function GABRA1 variant (p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gjerulfsen, Cathrine E., Mieszczanek, Tomasz S., Johannesen, Katrine M., Liao, Vivian W. Y., Chebib, Mary, Nørby, Helene A. J., Gardella, Elena, Rubboli, Guido, Ahring, Philip, Møller, Rikke S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424645/
https://www.ncbi.nlm.nih.gov/pubmed/37434477
http://dx.doi.org/10.1002/acn3.51838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424645/
https://www.ncbi.nlm.nih.gov/pubmed/37434477
http://dx.doi.org/10.1002/acn3.51838

Ejemplares similares